Lapatinib for the treatment of breast cancer in the People’s Republic of China
Hongjiang Wang Department of Breast Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China Abstract: Lapatinib is an oral, small-molecule, reversible inhibitor of both epidermal growth factor receptor and human epidermal growth factor receptor...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/lapatinib-for-the-treatment-of-breast-cancer-in-the-peoplersquos-repub-peer-reviewed-article-OTT |